Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deffered RevenueNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Zai Lab (ZLAB) Cash & Equivalents: 2018-2024

Historic Cash & Equivalents for Zai Lab (ZLAB) over the last 7 years, with Dec 2024 value amounting to $449.7 million.

  • Zai Lab's Cash & Equivalents rose 16.41% to $717.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $717.2 million, marking a year-over-year increase of 16.41%. This contributed to the annual value of $449.7 million for FY2024, which is 43.09% down from last year.
  • Per Zai Lab's latest filing, its Cash & Equivalents stood at $449.7 million for FY2024, which was down 43.09% from $790.2 million recorded in FY2023.
  • Over the past 5 years, Zai Lab's Cash & Equivalents peaked at $1.0 billion during FY2022, and registered a low of $442.1 million during FY2020.
  • For the 3-year period, Zai Lab's Cash & Equivalents averaged around $749.4 million, with its median value being $790.2 million (2023).
  • As far as peak fluctuations go, Zai Lab's Cash & Equivalents surged by 482.25% in 2020, and later crashed by 43.09% in 2024.
  • Zai Lab's Cash & Equivalents (Yearly) stood at $442.1 million in 2020, then surged by 118.06% to $964.1 million in 2021, then climbed by 4.60% to $1.0 billion in 2022, then dropped by 21.65% to $790.2 million in 2023, then slumped by 43.09% to $449.7 million in 2024.